James Lebar serves as Executive at Zomedica Pharmaceuticals Corp., where they oversee executive responsibilities. Since joining the company, James Lebar has executed 2 insider transactions totaling $430.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 28, 2018 involved selling 200,000 shares valued at $430.0K.
James Lebar currently holds 20,000 shares of Zomedica Pharmaceuticals Corp. (ZOM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Lebar has been a net seller of ZOM stock. They have purchased $0 and sold $430.0K worth of shares.
James Lebar's most recent insider trade was on Aug 28, 2018, when they sold 200,000 shares at $2.15 per share.
Get notified when new Form 4 filings are submitted
| $0.20 |
| Discretionary |